Novartis India Ltd (NOVARTIND) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 333626, "name": "Novartis India", "stock_name": "Novartis India", "full_name": "Novartis India Ltd", "name_url": "stocks-analysis/novartis-india", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,000.55", "chg": 9.25, "chgp": "0.93%", "dir": 1, "prev_price": "991.30", "mcapval": "2,453.00 Cr", "mcap": "Small Cap", "scripcode": 500672, "symbol": "NOVARTIND", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE234A01025", "curr_date": "Apr 10", "curr_time": "", "bse_nse_vol": "18.81 k", "exc_status": "Active", "traded_date": "Apr 10, 2026", "traded_date_str": "2026 04 10", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/novartis-india-333626-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Novartis India Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/novartis-india-ltd-is-rated-sell-by-marketsmojo-3941610", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NovartisIndiaLt_mojoScore_3941610.png", "date": "2026-04-10 10:10:03", "description": "Novartis India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 10 April 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance." }, { "title": "Novartis India Ltd Shows Technical Momentum Shift Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-shows-technical-momentum-shift-amid-mixed-indicator-signals-3938525", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NovartisIndiaLt_technicaldot_3938525.png", "date": "2026-04-09 08:01:34", "description": "Novartis India Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. Despite this positive tilt, the stock’s technical indicators present a mixed picture, with some signals pointing to strength while others suggest caution. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the pharmaceutical company’s near-term prospects." }, { "title": "Golden Cross Confirmed: Do Novartis India Ltd's Other Technical Indicators Agree?", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3938272", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NovartisIndiaLt_goldencross_3938272.png", "date": "2026-04-08 18:00:16", "description": "The 50-day moving average has crossed above the 200-day moving average for Novartis India Ltd, signalling a golden cross on 8 Apr 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a more nuanced picture." }, { "title": "Novartis India Gains 4.81%: Technical Shift and Mixed Financial Signals Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-gains-481-technical-shift-and-mixed-financial-signals-shape-the-week-3932404", "imagepath": "", "date": "2026-04-05 10:00:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>30 Mar:</strong> Rating upgraded to Sell from Strong Sell; stock closes at Rs.970.80 (-0.99%)</p>\n <p><strong>1 Apr:</strong> Sharp rebound with 4.45% gain to Rs.1,014.00 on heavy volume</p>\n <p><strong>2 Apr:</strong> Continued momentum with 1.36% rise to Rs.1,027.75</p>\n <p><strong>Weekly Summary:</strong> Stock gains 4.81% vs Sensex decline of 0.29%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.980.55</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</di..." }, { "title": "Novartis India Ltd Upgraded to Sell: A Detailed Analysis of the Rating Change", "link": "https://www.marketsmojo.com/news/stock-recommendation/novartis-india-ltd-upgraded-to-sell-a-detailed-analysis-of-the-rating-change-3923509", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NovartisIndiaLt_mojoScore_3923509.png", "date": "2026-03-30 08:03:59", "description": "Novartis India Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 27 March 2026, driven primarily by a shift in technical indicators despite ongoing financial challenges. The pharmaceutical company’s Mojo Score has improved to 34.0, reflecting a more balanced outlook amid mixed fundamentals and valuation concerns." }, { "title": "Novartis India Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-3923243", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NovartisIndiaLt_technicaldot_3923243.png", "date": "2026-03-30 08:00:36", "description": "Novartis India Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. The stock’s recent price action, combined with mixed readings from MACD, RSI, moving averages, and other momentum oscillators, suggests a cautious outlook for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Novartis India Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/novartis-india-ltd-is-rated-strong-sell-3909623", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NovartisIndiaLt_mojoScore_3909623.png", "date": "2026-03-24 10:10:41", "description": "Novartis India Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 24 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Novartis India Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/novartis-india-ltd-is-rated-strong-sell-3888304", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NovartisIndiaLt_mojoScore_3888304.png", "date": "2026-03-13 10:10:43", "description": "Novartis India Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Novartis India Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/novartis-india-ltd-is-rated-strong-sell-3863965", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NovartisIndiaLt_mojoScore_3863965.png", "date": "2026-03-02 10:10:49", "description": "Novartis India Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with the latest comprehensive analysis." } ], "total": 223, "sid": "333626", "stock_news_url": "https://www.marketsmojo.com/news/novartis-india-333626" }, "announcements": [ { "caption": "Disclosure Under Regulation 31(4) Of The SEBI (Substantial Acquisition Of Shares And Takeover Regulations 2011)", "datetime": "07-Apr-2026", "details": "Disclosure under regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover Regulations 2011).", "source": "BSE" }, { "caption": "Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors Of Novartis India Limited (The Company) And Closure Of Trading Window.", "datetime": "31-Mar-2026", "details": "Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 inter alia to consider and approve The Audited Financial Results of the company for the quarter and financial year ended March 31 2026.", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "31-Mar-2026", "details": "Intimation of meeting of Board of Directors of Novartis India Limited(the Company) and Closure of Trading Window.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "12 May 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Novartis India Ltd has declared <strong>500%</strong> dividend, ex-date: 23 Jul 25", "dt": "2025-07-23", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

30 Mar: Rating upgraded to Sell from Strong Sell; stock closes at Rs.970.80 (-0.99%)

1 Apr: Sharp rebound with 4.45% gain to Rs.1,014.00 on heavy volume

2 Apr: Continued momentum with 1.36% rise to Rs.1,027.75

Weekly Summary: Stock gains 4.81% vs Sensex decline of 0.29%

Week Open

Rs.980.55

Week CloseRead full news article

Novartis India Ltd Upgraded to Sell: A Detailed Analysis of the Rating Change

2026-03-30 08:03:59

Novartis India Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 27 March 2026, driven primarily by a shift in technical indicators despite ongoing financial challenges. The pharmaceutical company’s Mojo Score has improved to 34.0, reflecting a more balanced outlook amid mixed fundamentals and valuation concerns.

Read full news article

Novartis India Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals

2026-03-30 08:00:36

Novartis India Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. The stock’s recent price action, combined with mixed readings from MACD, RSI, moving averages, and other momentum oscillators, suggests a cautious outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Novartis India Ltd is Rated Strong Sell

2026-03-24 10:10:41

Novartis India Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 24 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Novartis India Ltd is Rated Strong Sell

2026-03-13 10:10:43

Novartis India Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Novartis India Ltd is Rated Strong Sell

2026-03-02 10:10:49

Novartis India Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with the latest comprehensive analysis.

Read full news article